Organisation paid for research Program year 2025 Source: CMS Open Payments

Conduct Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$964,072

198 payments

Through program year 2025, Conduct Clinical Trials is reported as receiving $964,072 in research payments, across 198 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$42,550	11
2024	Research	$201,812	17
2023	Research	$224,833	21
2022	Research	$262,764	79
2021	Research	$42,200	15
2020	Research	$10,725	24
2019	Research	$179,188	31

Breakdown

Who paid Research payments · program years 2019–2025

CapsoVision, Inc. $361,960 9 payments
Takeda Pharmaceuticals U.S.A., Inc. $203,700 78 payments
Ironwood Pharmaceuticals, Inc $91,707 6 payments
Moderna TX, Inc. $89,505 33 payments
Astute Medical, Inc. $80,859 40 payments
Shire North American Group Inc $50,500 16 payments
GlaxoSmithKline, LLC. $35,850 5 payments
Dova Pharmaceuticals $30,981 8 payments
Teva Pharmaceuticals USA, Inc. $11,300 1 payment
Amgen Inc. $6,000 1 payment

Studies the money was for Research payments · program years 2019–2025

Cln-Cvi-5794 $361,960 9 payments
Eva-25185-00 : Validation Study for A Gastroparesis Screening Tool $89,500 18 payments
C3718-301 $83,297 4 payments
AST-017 Healthy Adult $80,859 40 payments
EVA-25185: Gastroparesis Screener and EQ-5D Psychometric Study $72,750 21 payments
A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adolescents 12 to <18 years of age $61,980 20 payments
Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. $30,981 8 payments
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multic $19,275 3 payments
The Imagine Study: A Phase 3B Open Label, Single Arm Study to Assess T $16,575 2 payments
A Study of Tak-105 in Healthy Adults $15,775 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.